Omega 3 Supplements Market Size, Share & Trends Analysis Report By Source (Fish, Krill, Algal), By Form (Tablets, Soft Gels, Capsules, Others), By End Use, By Functionality, By Distribution Channel, And Segment Forecasts, 2025 - 2030

Omega 3 Supplements Market Trends

The global omega 3 supplements market size was valued at USD 7.68 billion in 2024 and is expected to expand at a CAGR of 9.1% from 2025 to 2030. The market growth is attributed to the increasing consumer awareness of the health benefits associated with omega-3 fatty acids, such as cognitive function, improved cardiovascular health, and anti-inflammatory properties. Furthermore, the rising prevalence of lifestyle-related diseases, including heart disease and arthritis, is also fueling demand for these supplements.

The growing aging population seeks omega-3 for its potential in managing age-related conditions. Government initiatives and regulations supporting the use of omega-3 supplements in various applications further bolster market growth. For instance, the U.S. Food and Drug Administration (FDA) has announced qualified health claims for EPA and DHA omega-3 consumption, acknowledging their role in reducing the risk of hypertension and coronary heart disease.

An increasing number of people are incorporating these supplements into their daily routines. For instance, a report by the National Institutes of Health indicates that millions of individuals in the U.S. regularly consume omega-3 supplements to support their overall health and well-being. This growing consumer base is a testament to the rising awareness and acceptance of the benefits associated with omega-3 fatty acids.

Brand name, nutritional value, and product safety are some factors that influence consumers’ buying decisions. Awareness through various forms of media, including electronic and print, about the benefits offered by omega 3-based supplements is also likely to influence buying behavior. Growth in fish consumption is expected to continue, especially in developing countries. Omega 3 supplements are primarily produced from fish oil. However, uneven fish capture and growing demand for fish from other application sources reduce their availability at a lower cost, restraining market growth.

Source Insights

The fish oil segment dominated the market with the largest revenue share of 61.5% in 2024. Fish oil is widely recognized as one of the richest sources of EPA and DHA, the two most beneficial omega-3 fatty acids linked to numerous health benefits, including improved cardiovascular health, cognitive function, and anti-inflammatory properties. The extensive body of scientific research supporting these benefits has significantly increased consumer trust and preference for fish oil supplements. Additionally, the relatively lower cost and higher availability of fish oil compared to other omega-3 sources, such as krill oil or algae oil, make it an attractive option for consumers. Furthermore, the increasing adoption of fish oil supplements by athletes and fitness enthusiasts, who use them for muscle recovery and joint health, further drives market growth.

In December 2024, Coromega introduced Coromega Max Gold, an advanced high-concentrate omega-3 fish oil supplement delivering 3,000 mg of omega-3 fatty acids per daily dose, including 1,560 mg of EPA and 1,060 mg of DHA. Designed for maximum health benefits, it supports heart health, cognitive function, and joint mobility. Max Gold is formulated for optimal wellness and high absorption, using wild-caught, deep-sea fish. This premium supplement is ideal for consumers aiming to improve their omega-3 intake and overall health.

The krill oil segment is expected to grow at the fastest CAGR over the forecast period. Krill oil is often perceived as a more sustainable and environmentally friendly option than fish oil, as krill harvesting has a lower impact on marine ecosystems. This aligns well with the growing consumer preference for eco-friendly and sustainable products. The unique phospholipid structure of krill oil also enhances the bioavailability of omega-3 fatty acids, making them easier for the body to absorb and utilize.

Form Insights

The soft gels segment is expected to witness a significant CAGR over the forecast period. Factors such as ease of swallowing and taste masking make soft gels more appealing to consumers than tablets or capsules. Additionally, soft gels offer enhanced absorption and bioavailability, leading to faster nutrient delivery and increased effectiveness. They are also convenient and user-friendly, contributing to their popularity among consumers. Furthermore, the gelatin shell protects the omega-3 oils from oxidation, extending their shelf life and maintaining their quality. Overall, these benefits, combined with technological advancements and the well-documented health benefits of Omega-3, drive the industry's demand for soft gel supplements.

The capsules segment is expected to grow at the highest CAGR over the forecast period. Capsules are highly convenient and easy to consume, making them a popular choice among consumers who prefer a no-fuss method of taking their supplements. It also provide precise dosing, ensuring that users receive the exact amount of omega-3s it need without the risk of under- or overconsumption. The encapsulation technology helps protect the delicate omega-3 fatty acids from oxidation and degradation, thereby preserving their potency and efficacy.

Functionality Insights

The cardiovascular health segment dominated the market with the largest revenue share in 2024. Rising occurrences of cardiovascular diseases owing to the inactive and slow lifestyle, especially in the age group of 30 to 40 years, and fluctuating dietary patterns are projected to boost cardiac health application segment over the next few years. According to the American Heart Association (AHA), globally 17.3 million people die per year because of cardiovascular diseases which incur direct & indirect coats of over USD 320.billion. In addition, people in the North America, especially the U.S., reported higher cholesterol levels of about 43.0%and 33.0% of high blood pressure. This trend is expected to drive the growth in demand for pharma-grade Omega-3 dietary supplements for treating coronary heart diseases, hypertension, and cholesterol.

The eye diseases segment is expected to grow at the fastest CAGR over the forecast period. The segment is driven by rising R&D and the introduction of new products to control nutrition-related diseases. The demand in eye diseases and eye care section is localized as it highly depends upon public awareness regarding DHA deficiencies. Manufacturers in this application segment are working on introducing different product forms.

End Use Insights

The adults segment dominated the market with the largest revenue share in 2024. The adult population ranges from 31 to 50 years old. These are mainly working populations with significant purchasing power, often experiencing chronic illnesses due to their demanding lifestyles. Furthermore, women tend to be more proactive about preventive health and are more likely to incorporate supplements into an established health & wellness regimen. Besides, several health benefits of omega 3 fatty acids as it help in fighting anxiety and depression, reduce symptoms of metabolic syndrome, can fight inflammation, and can improve mental disorders are expected to attract adult population towards the product over the forecast period.

The infants segment is expected to grow at the fastest CAGR over the forecast period.  Infancy is a critical period for growth and development, and omega-3 fatty acids, such as EPA and DHA, play a vital role in supporting these processes. There is a growing demand for infant nutrition products, including omega-3 supplements, due to increasing awareness of their health benefits. Regulations often support the inclusion of omega-3s in infant formulations, which encourages manufacturers to develop these products. Omega-3s are recognized for their benefits in neurodevelopment, vision, and immune system support, making them a sought-after ingredient in infant nutrition. Overall, these factors contribute to the growth and development of the omega-3 supplements market for infants.

Distribution Channel Insights

The OTC channel dominated the market with the largest revenue share in 2024. The convenience and accessibility of OTC omega-3 supplements have driven their popularity, as more individuals seek to manage their health independently. Additionally, the rising awareness of the health benefits associated with omega-3 fatty acids, such as improved heart health and cognitive function, has further fueled the demand for these supplements.

The prescribe channel is expected to grow at the highest CAGR over the forecast period. This surge is primarily driven by increased recognition of the therapeutic benefits of omega-3 supplements in managing specific medical conditions, such as hypertriglyceridemia and cardiovascular diseases. Healthcare professionals are increasingly prescribing these supplements to patients, further contributing to the market's expansion. The growing trust in physician recommendations and the perceived efficacy of prescription-grade omega-3 supplements are key factors propelling this segment's rapid growth.

Regional Insights

North America omega 3 supplements industry dominated the global market with the largest revenue share of 36.9% in 2024. Increasing use of food supplements with reduced calorie levels and high nutritional content. Furthermore, increasing awareness about the consumption of supplement products in Mexico on account of new product launches is expected to promote the application scope of omega 3 supplements over the forecast period. Cardiac health is one of the primary application segments of the omega 3 supplements market in North America since about 610,000 people die from heart diseases in the U.S. every year. Heart disease is a primary cause of death among several men & women in the region. Several Americans have realized the importance of diet and exercise in maintaining health and prolonging life, thus, leading to high demand for omega 3 supplements in the region.

U.S. Omega 3 Supplements Market Trends

The U.S. omega 3 supplements industry is expected to grow significantly over the forecast period. Increasing consumer awareness of the health benefits associated with omega-3 fatty acids, such as improved heart health, cognitive function, and overall well-being. Additionally, supportive government initiatives, such as the FDA's qualified health claims for omega-3 supplements, have further boosted consumer confidence and market demand. For instance, The Office of Dietary Supplements (ODS) within the National Institutes of Health (NIH) plays a crucial role by funding research and providing valuable information on the benefits and safety of omega-3 supplements. Additionally, the FDA regulates the manufacturing and labeling of dietary supplements, ensuring that products meet quality standards and are free from contaminants

Europe Omega 3 Supplements Market Trends

Europe omega 3 supplements industry held a considerable share in 2024. The growing health consciousness among consumers has significantly contributed to the demand for omega-3 supplements. Consumers are increasingly aware of the benefits of omega-3 fatty acids, such as improved heart health and cognitive function, which has fueled the market's growth. Additionally, the rise in popularity of plant-based and vegan diets has led to an increased demand for plant-based omega-3 sources, such as chia seeds, flaxseeds, and microalgae. Furthermore, latest product launches in this region by key players is driving market growth such as, in May 2024, NYO3's Royal-boost Antarctic Krill Oil, introduced at Vitafoods Europe. This new product features innovative water-soluble technology that enhances absorption rates, offering a more efficient way to deliver omega-3 benefits. The product is part of NYO3's commitment to sustainability and high-quality standards, ensuring that consumers receive pure and effective omega-3 supplement.

Asia Pacific Omega 3 Supplements Market Trends

Asia Pacific omega 3 supplements industry is expected to grow at the fastest CAGR over the forecast period. Several factors driving regions growth are increasing health consciousness among consumers, a rising aging population prioritizing cognitive health, and high birth rates boosting demand for infant nutrition. Additionally, the popularity of plant-based diets has led to a surge in demand for algae-based omega-3 supplements. Furthermore, innovations by several key players such as, in June 2024,Daewoong Bio launched CRA-TG, a combination of the hyperlipidemia drug rosuvastatin and omega-3, aimed at reducing triglyceride levels in patients. This new addition expands Daewoong Bio's hyperlipidemia treatment lineup, which includes nine products such as Atorvastatin Tablets and Oma-TG Soft Capsule. CRA-TG has demonstrated improved lipid profiles and enhanced tolerability and stability. The product features patented Multi-Layer Capsule Coating Technology, ensuring ingredient integrity and safety, while maintaining a similar size to existing omega-3 products like Oma-TG.

India is expected to grow at the highest CAGR during the forecast period. Increasing awareness of health benefits, rising disposable incomes, and urbanization fuel demand for preventive healthcare solutions and nutritional supplements. The prevalence of chronic diseases, such as cardiovascular conditions and diabetes, also plays a significant role in driving the market, as consumers seek to mitigate health risks through dietary supplements. Additionally, the expanding middle-class population and growing adoption of Western dietary habits contribute to the market's positive outlook. South India, in particular, emerges as a major market due to its higher health consciousness and access to Omega-3 rich foods.

Key Omega 3 Supplements Company Insights

Some key companies in the omega 3 supplements industry include Nordic Naturals, NutriGold, Reckitt Benckiser Group PLC. Pharma Nord Inc., i-Health, Inc., AKER BIOMARINE, and others.

• NutriGold is a leading company in the nutraceutical industry known for its high-quality supplements. These include a range of omega-3 supplements, such as the NutriGold Triple Strength Omega-3 Fish Oil. This product features 2100 mg of omega-3 per serving, providing a high concentration of EPA and DHA, which are essential for cardiovascular and brain health. NutriGold’s supplements are made using patented technology and are certified for purity and sustainability.

• Reckitt Benckiser Group PLC is a global consumer health and hygiene company. The company’s focus on health and wellness includes omega-3 supplements, part of its broader portfolio to support overall health and well-being. Reckitt Benckiser’s products are developed with a strong emphasis on scientific research and innovation, ensuring high-quality and effective supplements.

Recent Developments

• In January 2024, Ritual launched the Omega-3 DHA + EPA supplement, offering a 500 mg dose of omega-3 fatty acids in a 2:1 ratio of DHA and EPA. Sourced sustainably from microalgae in La Forêt-Fouesnant, France, and manufactured with patented technology to reduce oxidation, the oil ensures minimal burp-back. It is infused with natural citrus oil for improved taste. Part of Ritual's Made Traceable transparency program, the supplement is vegan, third-party tested, and free from gluten, soy, and major allergens, and comes in 100% recycled packaging.

Omega 3 Supplements Market Report Scope

Global Omega 3 Supplements Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global omega 3 supplements market report based on source, form, functionality, end use, distribution channel, and region:

• Source Outlook (Revenue, USD Million, 2018 - 2030)

  • Fish Oil

  • Krill Oil

  • Algae Oil

  • Others

• Form Outlook (Revenue, USD Million, 2018 - 2030)

  • Tablets

  • Capsules

  • Soft Gels

  • Others

• Functionality Outlook (Revenue, USD Million, 2018 - 2030)

  • Cardiovascular Health

  • Brain, Nervous System & Mental Health

  • Eye Diseases

  • Diabetes

  • Others

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Adults

  • Geriatric

  • Pregnant Women

  • Children

  • Infants

• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2028)

  • OTC

    • Supermarkets/ Hypermarkets/Food Stores

    • Drug Stores & Pharmacies

    • Online Retailers

    • Others

  • Prescribed

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Netherlands

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • New Zealand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • UAE